moderna
Moderna and Flagship Pioneering: Noubar Afeyan
In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. N…
New dino, vaccine shake-ups, dirty air risks
In this Science Quickly news roundup, we look at the Food and Drug Administration’s surprising change of heart on reviewing Moderna’s mRNA flu shot, a promising…
Extraordinary leaps need solid foundations, part 1, w/Moderna CEO Stéphane Bancel
If you're launching a moonshot, success depends on how you manage the trajectory of risk. When Stéphane Bancel became Moderna's first CEO, the biotech start-up …
Extraordinary leaps need solid foundations, part 2, w/Moderna CEO Stéphane Bancel
A diverse network of collaborators is key when making scale leaps. Moderna CEO Stéphane Bancel has cultivated a wide network of scientists, business leaders, an…
